Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine for Imbalance in Multiple Sclerosis
NCT01444300Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in multiple sclerosis (MS), sponsored by Oregon Health & Science University. Started Sep 2011; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01444300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444300.